Clinical Trial Update: Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing quetiapine XR as monotherapy versus augmentation with lithium in treatment-resistant depression. Results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Lithium carbonate (Lithium carbonate)
• Quetiapine XR (quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Major Depressive Disorder, Treatment Resistant Depression | Phase 3 | Status: COMPLETED | Results posted: 2012-05-23